Here are 14 key notes on spine and orthopedic device companies this week.
Bioventus named a new vice president of business development, Thomas Umbel as well as a new vice president of strategy and general counsel, Jeanne Forneris.
BONESUPPORT received the Frost & Sullivan 2015 Growth Capital Investment Award.
Captiva secured $8.5 million in an oversubscribed Series D financing.
Ellipse Technologies received FDA 510(k) clearance to market its next generation external remote controller for use with the MAGnetic Expansion Control Spinal Bracing and Distraction System, or MAGEC system.
The first two patients to receive InVivo's Neuro-Spinal Scaffold for spinal cord injury are showing improvement three-to-six months after surgery.
LDR received an "outperform" rating by analysts at RBC Capital Markets.
MEDTECH sold three ROSA Surgical Robots in Asia.
MiMedx announced the publication of its peer-reviewed scientific study, which proves the link between the properties of its CollaFix fibers and beginning of tendon regeneration.
Novation also recognized MiMedx with the Novation Innovative Technology award for 2015.
The consensus, or mean, target price of the Wall Street analysts covering NuVasive is $54.9.
Paradigm Spine published new results from a clinical trial examining the coflex Interlainar Stabilization after decompression for lumbar spinal stenosis.
SI-BONE presented the results from the INSITE study at the Annual International Society for the Advancement of Spine Surgery meeting earlier this year.
Vinita Bali, a Smith & Nephew insider, purchased 2,400 shares on the open market.
Spinal Kinetics presented the results of a two-year, multi-center outcomes trial for treating lumbar degenerative disc disease using the company's Spinal Kinetics M6 cervical disc prosthesis.